Opdivo® (nivolumab)
for Lymphoma

Opdivo (nivolumab) is an immunotherapy used to treat various cancers, including melanoma, non-small cell lung cancer, mesothelioma, renal cell carcinoma, Hodgkin lymphoma, and others. It is given as an intravenous infusion every 2 to 4 weeks, either alone or with other treatments like Yervoy or chemotherapy. Opdivo works by boosting the immune system’s ability to attack cancer cells, slowing tumor growth and spread.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lymphoma